Great Lakes Advisors, LLC Aprea Therapeutics, Inc. Transaction History

Great Lakes Advisors, LLC

  • $11.1 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021
SELL
$3.43 - $5.63 $61,379 - $100,748
-17,895 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$4.05 - $5.5 $72,474 - $98,422
17,895 New
17,895 $87,000

Others Institutions Holding APRE

# of Institutions
2
Shares Held
899
Call Options Held
0
Put Options Held
0
View Full List

About Aprea Therapeutics, Inc.

APRE Quotes by TradingView
  • Ticker APRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...
More about APRE
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email